montelukast sodium (Camber Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the montelukast sodium drug offered from Camber Pharmaceuticals, Inc.. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Camber Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | montelukast sodium |
SUBSTANCE NAME: | MONTELUKAST |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, CHEWABLE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-05-27 |
END MARKETING DATE: | 0000-00-00 |
montelukast sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | montelukast sodium from Camber Pharmaceuticals, Inc. |
LABELER NAME: | Camber Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2015-05-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 31722-727_cd08fa68-33ec-4627-b399-03d038cc00c2 |
PRODUCT NDC: | 31722-727 |
APPLICATION NUMBER: | ANDA204093 |
Other MONTELUKAST Pharmaceutical Manufacturers / Labelers: